DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Pipeline Advances NCTY Q1 2012 Earnings Narrower Loss Than Expected as Revenue Picture Remains Unclear MRLN Q1 2026 Earnings Record EPS Surge Driven by Cost Controls Though Revenue Details Remain Unclear ASUR Q1 2026 Earnings EPS Surprises to the Upside Despite Broader Market Headwinds PERI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Highwoods Properties Inc HIW Q1 2026 Earnings EPS Surges 161 Above Estimates GPN Q1 2026 Earnings EPS Beats Estimates by 366 as Stock Edges Higher Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline NAT Q4 2025 Earnings EPS Misses Estimates by 56 Amid Weak Tanker Market APPN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency PPBT Q1 2025 Earnings Biotech Reports Net Loss Amid Ongoing Clinical Development Corteva Inc CTVA Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution TOI Q1 2026 Earnings Strong Earnings Beat Amidst Limited Revenue Disclosure